购物车
0
有库存
HIT219152517
 sdf 文件
结构编辑
类似物检索
HIT219152517
  • HIT ID:HIT219152517
  • Cas No:
  • 常用名:IVMT-Rx-3
  • IUPAC:(4S)-4-[(2S)-3-carbamoyl-2-[(2S,3R)-2-{1-[(2,5-dimethyl-4-{2-oxo-1,8,10,12-tetraazatricyclo[7.3.0.0^{3,7}]dodeca-3(7),8,10-triene-11-amido}phenyl)carbamoyl]-3,6,9,12,15-pentaoxaoctadecan-18-amido}-3-hydroxybutanamido]propanamido]-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid; trifluoroacetic acid
    IUPAC:(4S)-4-[(2S)-3-carbamoyl-2-[(2S,3R)-2-{1-[(2,5-dimethyl-4-{2-oxo-1,8,10,12-tetraazatricyclo[7.3.0.0^{3,7}]dodeca-3(7),8,10-triene-11-amido}phenyl)carbamoyl]-3,6,9,12,15-pentaoxaoctadecan-18-amido}-3-hydroxybutanamido]propanamido]-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid; trifluoroacetic acid
  • InChI key:YNZDNUMEGIYURC-MXAJGPDHSA-N
  • 分子式:C69H90F3N13O24
  • 分子量:1542.541
  • 氢键供体数 (HBD):
  • 氢键受体数 (HBA):
  • LogP:
  • SMILES:OC(=O)C(F)(F)F.CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCC(=O)Nc1cc(C)c(NC(=O)c2nc3nc4CCCc4c(=O)n3[nH]2)cc1C)[C@@H](C)O)C(O)=O
    SMILES:OC(=O)C(F)(F)F.CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCC(=O)Nc1cc(C)c(NC(=O)c2nc3nc4CCCc4c(=O)n3[nH]2)cc1C)[C@@H](C)O)C(O)=O
  • IVMT-Rx-3是针对SDCBP的PDZ1和PDZ2结构域,特别是MDA-9/Syntenin的抑制剂。该化合物能够中断MDA-9/Syntenin与Src之间的互动,减少NF-κB的激活,并且降低MMP-2/MMP-9的表达量,从而抑制了黑色素瘤的转移。
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    纯度
    -
    待询
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~